Healthcare Stock Receives Rs 256 Crore From Brand Sale, Transaction With Wipro Completed
Join Us
Follow Us
TTK Healthcare has completed the sale of its EVA and Good Home brands after receiving Rs 256 crore plus applicable GST as transaction consideration.
✨ Key Takeaways
On Friday, Indian equity benchmark indices traded higher, with the benchmark Nifty 50 index rose 63 points (0.27 per cent) to 23,937. Amid the market movement, TTK Healthcare share price fell 0.27 per cent to Rs 1,100.20 after the company announced completion of the sale of its EVA and Good Home brands to Wipro Enterprises Private Limited for Rs 256 crore plus applicable GST.
Searching for the Next Multibagger Opportunity?
Explore DSIJ’s Multibagger Pick - a research-driven service focused on identifying fundamentally strong companies with the potential to generate exceptional long-term returns.
Download Service BrochureTTK Healthcare Limited informed exchanges that the transaction related to the sale of its EVA and Good Home brands has been completed. The company received the agreed consideration in cash from Wipro Enterprises Private Limited following the completion of definitive agreements entered into on July 23, 2026.
Brand Divestment Completed
The company had entered into definitive agreements with Wipro Enterprises Private Limited for the transfer of the EVA and Good Home brands. As part of the transaction closure, TTK Healthcare received Rs 256 crore along with applicable GST as consideration in cash.
The completion of the deal marks a strategic development for TTK Healthcare as the company exits ownership of these brands following the transfer agreement. The proceeds from the transaction provide the company with additional financial resources.
Transaction Closure Follows Earlier Agreement
TTK Healthcare had previously communicated details regarding the proposed sale of the EVA and Good Home brands. The company has now confirmed that the closing of the transaction stands completed after receiving the consideration amount from Wipro Enterprises.
The company submitted the disclosure under Regulation 30 of the SEBI Listing Regulations, providing an update on the completion of the brand sale transaction.
About the Company:
TTK Healthcare Limited is an Indian healthcare company engaged in consumer healthcare, medical devices and other healthcare-related businesses. The company operates across various segments, including healthcare products and wellness solutions, catering to domestic and international markets.
Also Read - Sterlite Technologies Shares Hit 5% Upper Circuit as Company Unveils Ambitious FY29 Roadmap; FIIs and DIIs Increase Stake
Disclaimer: The article is for informational purposes only and not investment advice.